Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
Authors
Keywords
-
Journal
EBioMedicine
Volume 83, Issue -, Pages 104232
Publisher
Elsevier BV
Online
2022-08-19
DOI
10.1016/j.ebiom.2022.104232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
- (2022) Paul A. Christensen et al. AMERICAN JOURNAL OF PATHOLOGY
- Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
- (2022) Alba Escalera et al. Cell Host & Microbe
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
- (2022) Kenrie P. Y. Hui et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- (2022) Rigel Suzuki et al. NATURE
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
- (2022) Daichi Yamasoba et al. CELL
- Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
- (2022) Ryuta Uraki et al. NATURE
- Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
- (2022) Jingyou Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
- (2022) Paul Elliott et al. Nature Communications
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2
- (2021) Haibo Wu et al. Cell Host & Microbe
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Infection of dogs with SARS-CoV-2
- (2020) Thomas H. C. Sit et al. NATURE
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search